HB0034 for severe pustular psoriasis flare
Treatments studied
Part of Skin clinical trials.
This study tests an experimental drug called HB0034 for people with a sudden, severe flare of generalized pustular psoriasis (GPP). It aims to see if the drug can safely clear the pustules and improve symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently having a moderate-to-severe flare of pustular psoriasis (new or worsening pustules covering at least 5% of your body).
- You are willing to use reliable birth control during the study and for 6 months after the last dose (if you could become pregnant or get someone pregnant).
- You are not pregnant or breastfeeding.
- You do not have other active autoimmune diseases (like rheumatoid arthritis, lupus, or inflammatory bowel disease) that require immune-suppressing treatment.
- You are not at high risk for serious infections (e.g., from HIV, organ transplant, or recent severe infection).
- You have not had a live vaccine in the past 6 weeks and do not plan to get one during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral medication, CS32582, for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing skin symptoms like redness, thickness, and scaling.
This trial tests an experimental pill called D-2570 for people with moderate to severe plaque psoriasis. It aims to see if the pill can safely improve skin symptoms like redness, scaling, and thickness.
This trial tests an investigational drug, HB0017, in adults with moderate to severe plaque psoriasis. If you have had psoriasis for at least 6 months and have not used certain biologic treatments, you may be able to join.
This trial tests a new medication (HS-10374) taken by mouth to see if it is safe and effective for people with moderate to severe plaque psoriasis. It might help reduce the redness, scaling, and thickness of psoriasis plaques.
This trial tests an experimental pill that may help clear psoriasis plaques. It is for people whose current topical treatments (creams or ointments) are not working well enough or cause side effects.
This study tests a new medicine (HS-20137) for moderate-to-severe plaque psoriasis, a condition causing thick, scaly patches on the skin. It aims to see if this medicine can safely reduce the severity of psoriasis and improve quality of life.
Hear when a new Generalized Pustular Psoriasis (GPP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.